Skip to main content
Infant Formula Recall Retirada del mercado de fórmula infantil

ALERT: ByHeart Recalls Whole Nutrition Infant Formula. Read more

AVISO IMPORTANTE: ByHeart retira del mercado su fórmula infantil Whole Nutrition. Aprender más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

Updates to the Preferred Drug List (PDL) for Androgenic agents, Macrolides-Ketolides, Antiviral, Bronchodilator and Growth Hormone drug classes

Date: November 8, 2023

Attention: All Providers

Effective Date: October 31, 2023

Call to action: Texas Health and Human Services (HHSC) moved select medication(s) listed below to “preferred” status due to various drug shortages at this time. We are notifying providers more options to prescribe your members if they cannot obtain their current medication(s). 

A summary of the changes is included below.

Impacted medications(s)
Preferred medication
Type of change
Effective Date
Androgel [B]
Testosterone Gel (TOPICAL) [G]
Generic now preferred
October 16, 2023
Valcyte [B]
Valganciclovir solution (ORAL) [G]
Generic now preferred
October 16, 2023
Nordotropin [B]
Omnitrope* (SQ) [B]
Other Growth Hormone(s) available
October 16, 2023
Genotropin [B]
Skytrofa* (SQ) [B]
Xopenex [B]
Levalbuterol solution [G]
Generic now preferred
October 31, 2023
Eryped [B]
Erythromycin solution [G]
Generic now preferred
November 7, 2023

* These medications also have a clinical prior authorization requirement.
 [B] Signals the medication is brand name
 [G] Signals the medication is generic

How this impacts providers: This change will allow providers to prescribe the preferred medication to your patients without requiring PDL prior authorization. Some of the preferred medications may continue to require clinical prior authorizations.

Next steps for providers: Texas Children’s Health Plan (TCHP) encourages providers to switch existing patients to the preferred medication so there is no disruption in patient’s therapy. The preferred drug list (PDL) can be found on the VDP website: https://www.txvendordrug.com/formulary/preferred-drugs

If you have any questions, please email TCHP Pharmacy Department at: TCHPPharmacy@texaschildrens.orgFor access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.